The question asks which pharmacokinetic step controls how fast a controlled release tablet's drug becomes available for absorption. Let's check each option against where it actually sits in the drug's journey through the body.
Only dissolution happens before absorption and only dissolution is the step deliberately engineered to be slow in a controlled release formulation.
The correct answer is Dissolution of the drug.
A typical skin cream consisting of stearic acid, potassium hydroxide, glycerin, water, preservative and perfume, would be commonly known as:
List I | List II | ||
|---|---|---|---|
| A | \(\Omega^{-1}\) | I | Specific conductance |
| B | \(∧\) | II | Electrical conductance |
| C | k | III | Specific resistance |
| D | \(\rho\) | IV | Equivalent conductance |
List I | List II | ||
|---|---|---|---|
| A | Constant heat (q = 0) | I | Isothermal |
| B | Reversible process at constant temperature (dT = 0) | II | Isometric |
| C | Constant volume (dV = 0) | III | Adiabatic |
| D | Constant pressure (dP = 0) | IV | Isobar |